Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- Economists, Industry and Regulatory Officials Talk over Pricy Med Issue at JPMA Seminar
September 6, 2016
- JMA Think Tank Calls for Rewarding Innovation with Subsidies, in Lieu of Pricing
September 1, 2016
- Drug Wholesalers See 8.3% Boost in Sales on Hep C Demand: JPWA
August 17, 2016
- JPMA Calls for Financial Support to Encourage R&D on Treatments for ARIs
August 15, 2016
- Sales Rep Number in Japan Logs Big Drop for 2nd Straight Year: Survey
August 12, 2016
- EFPIA Japan Calls for Relaxation of Japanese Vaccine Regulations: Vaccine Subcommittee Head
August 9, 2016
- NPO Petitions Academic Society to Clarify Reason for Deaths Associated with Xeplion
July 20, 2016
- Japan Biosimilar Association Up and Running with Four Member Firms
July 19, 2016
- JPMA Keen to Defend R&D Tax Credit System
July 8, 2016
- Generic Use Rate at 55.7% in FY2015, Up 3.7 Points: JGA
July 8, 2016
- EFPIA Japan Calls for Diversifying Vaccine Supply Sources to Prepare for Crises
July 7, 2016
- Drug Damage Watchdog Challenges Doctors’ View, Says HPV Vaccination Shouldn’t Be Recommended
July 5, 2016
- JMA Vice President Nakagawa Calls for Rules on Use of “Expensive Drugs”
June 27, 2016
- Yokokura Reelected for Third Term as JMA President
June 27, 2016
- NPO Asks MHLW to Take Steps to Ensure Proper Use of Xeplion
June 23, 2016
- PMDA Chief Brings Together Drug Makers, Tech Vendors to Compile Proposal on Digital Health
June 17, 2016
- Re-Pricing Rules Need Drastic Overhaul, Possible Abolishment Should Be Discussed for Z2: FPMAJ
June 14, 2016
- FPMAJ Report Warns of Repercussions from Sovaldi Price Slash
June 14, 2016
- Reimbursement Prices Kept Unchanged for Over 20% of Drugs: FPMAJ Survey
June 13, 2016
- FPMAJ Wants to Avoid Narrowing-Down of Premium-Eligible Products: Kamoya
June 13, 2016
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…